Lv1
54 积分 2025-09-26 加入
Discovery of AZD9750, an Orally Bioavailable Androgen Receptor Degrader for the Treatment of Prostate Cancer
13天前
已完结
A review of ethnobotanical uses, phytochemistry, and pharmacology of the genus Strychnos (Loganiaceae)
21天前
已完结
A comprehensive review of mechanistic insights into Platycladus orientalis (L.) Franco: integration of phytochemistry and pharmacology
21天前
已完结
Ilicicolin C suppresses the progression of prostate cancer by inhibiting PI3K/AKT/mTOR pathway
2个月前
已完结
Discovery of A031 as effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer
2个月前
已完结
Bavdegalutamide (ARV-110): a potent PROTAC androgen receptor degrader for the treatment of metastatic-castration resistant prostate cancer
2个月前
已完结
Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021)
3个月前
已完结
PTEN loss and PSGR overexpression promote cancer progression
4个月前
已完结
The prostate‐specific G‐protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to α‐methylacyl‐CoA racemase
4个月前
已完结
A comprehensive review on the chemical composition, pharmacological effects and quality evaluation of Gentiana straminea Maxim
5个月前
已完结
皖公网安备34019202002308
